emerging tech investing DIAGNOS to Hold its Annual General Meeting of Shareholders on September 30, 2026
emerging tech investing DIAGNOS Receives Saudi FDA Medical Device License for CARA System, Bringing AI-Assisted Retinal Image Analysis to Saudi Arabia
emerging tech investing DIAGNOS Receives Health Canada Medical Device Licence for CARA System, Bringing AI-Assisted Retinal Image Analysis to Canadian Optometrists
emerging tech investing DIAGNOS Submits Modified and Updated Health Canada Licence Application for CARA System Platform
emerging tech investing DIAGNOS Announces Grant of Stock Options and Adoption of Semi-Annual Reporting
emerging tech investing Emerging Growth Research Releases Flash Report on DIAGNOS, Highlighting Regulatory Catalysts and Commercialization Potential for CARA AI Platform
emerging tech investing DIAGNOS Successfully Completes the Renewal of US-FDA Medical Device Establishment Registration
Brixton Metals Enters into Option Agreement to Acquire a 100% Interest in the Silver Focused Silvergruvan Project in Sweden
